Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging
Authors:
- 29 June 2016
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 128 (33) , 9753-9757
Abstract
Glycogen synthase kinase‐3 (GSK‐3) regulates multiple cellular processes in diabetes, oncology, and neurology. N‐(3‐(1H‐1,2,4‐triazol‐1‐yl)propyl)‐5‐(3‐chloro‐4‐methoxyphenyl)oxazole‐4‐carboxamide (PF‐04802367 or PF‐367) has been identified as a highly potent inhibitor, which is among the most selective antagonists of GSK‐3 to date. Its efficacy was demonstrated in modulation of tau phosphorylation in vitro and in vivo. Whereas the kinetics of PF‐367 binding in brain tissues are too fast for an effective therapeutic agent, the pharmacokinetic profile of PF‐367 is ideal for discovery of radiopharmaceuticals for GSK‐3 in the central nervous system. A 11C‐isotopologue of PF‐367 was synthesized and preliminary PET imaging studies in non‐human primates confirmed that we have overcome the two major obstacles for imaging GSK‐3, namely, reasonable brain permeability and displaceable binding.Keywords
Funding Information
- U.S. Department of Energy (DE-AC02-06CH11357)
- National Institutes of Health (1K01DA038000)
This publication has 29 references indexed in Scilit:
- Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and ImagingTheranostics, 2016
- Tau in physiology and pathologyNature Reviews Neuroscience, 2015
- GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitorsNature Chemical Biology, 2014
- Lessons Learnt from Glycogen Synthase Kinase 3 Inhibitors Development for Alzheimer’s DiseaseCurrent Topics in Medicinal Chemistry, 2013
- Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's diseaseNeurobiology of Disease, 2012
- Pharmacological inhibitors of glycogen synthase kinase 3Trends in Pharmacological Sciences, 2004
- The glamour and gloom of glycogen synthase kinase-3Trends in Biochemical Sciences, 2004
- Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic miceThe EMBO Journal, 2001
- Localization and Developmental Changes of τ Protein Kinase I/Glycogen Synthase Kinase‐3β in Rat BrainJournal of Neurochemistry, 1994
- Molecular cloning and expression of glycogen synthase kinase‐3/factor A.The EMBO Journal, 1990